From: Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
 | n (%) |
---|---|
Age, mean (± SD) yrs | 69.4 (± 12.1) |
Gender (Male) | 338 (56.7) |
Tumor location | |
 Rectum | 251 (42.4) |
 Left-sided colon | 132 (22.3) |
 Right-sided colon | 209 (35.3) |
Tumor differentiation | |
 Well | 22 (3.7) |
 Moderate | 423 (71.3) |
 Poor | 138 (23.3) |
 Mucinous | 6 (1.0) |
Stage | |
 I | 62 (10.4) |
 II | 203 (34.1) |
 III | 234 (39.3) |
 IV | 94 (15.8) |
Lymph node count ≥12 | 413 (69.3) |
Positive lymph node | 293 (52.1) |
Received preoperative radiotherapya | 130 (21.7) |
Radically operated | 509 (86.3) |
Received chemotherapyb | 236 (39.6) |
 Adjuvant therapy | 171 (55.1) |
 First-line therapy | 101 (25.4) |
 Confirmed response to therapy | 74 (78.7) |
Relapsed | 160 (32.1) |
Status at last follow-up | |
 Dead | 362 (60.7) |
 Alive | 231 (38.8) |